PROVIDER PROFILE · NPI 1548436934

Mark GarzaMD

PRACTICEQUALITY ANESTHESIA SERVICES LLCSee all providers at this practice →

Interventional Pain ManagementFort Worth, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

203

Unique beneficiaries

—

Total services

1,113

Distinct HCPCS

Medicare payment

$62K

Peer benchmark

Total Medicare services vs. 175 Interventional Pain Management providers in TX — below median (cohort median 3,022).

PRESCRIBING · PART D · 2024

Total Rx claims

4,364

Beneficiaries

—

Total drug cost

$284K

Distinct drugs

Brand share

57.0%

Top prescribed drugs

Hydrocodone/Acetaminophen1,586 claims

Oxycodone Hcl/Acetaminophen283 claims

Gabapentin277 claims

Tizanidine Hcl216 claims

Tramadol Hcl204 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$834

Payment records

By payment type

Food and Beverage$834

REFERRAL NETWORK

Where Mark Garza's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Prasad Lakshminarasimhiah Physical Medicine and Rehabilitation · Frisco, TX	90	437
MEDICAL TOX LABS, LLC	54	202
CHOICE LABORATORY SERVICES, LLC	44	168
VELA, CRISTINA	28	121
Rohitha Kramadhati Anesthesiology · Tampa, FL	19	73
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	17	44

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history